Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018

Thursday, October 25, 2018 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, October 25, 2018 /PRNewswire/ --

  • Webcast to begin at 12:00pm
    ET
  • Focus on recent developments in synthetic lethality and bi-specific antibodies within oncology

Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation today

announced that the Company will host a live webcast in conjunction with its Oncology KOL Day on Tuesday, October 30, 2018 at 12:00pm ET in New York, NY.

A webcast of the presentation will be accessible live at 12:00pm ET and available to replay on Arix's website at https://arixbioscience.com/presentations.

For more information on the Event, please contact Arix.Event@burnsmc.com.

Enquiries    For more information on Arix, please contact: Arix Bioscience plc  Charlotte Parry, Head of Investor Relations +44(0)20-7290-1072 charlotte@arixbioscience.com  

Optimum Strategic Communications  Mary Clark, Supriya Mathur +44(0)203-714-1787 optimum.arix@optimumcomms.com

Burns McClellan (US Media & IR Enquiries)  Bill Slattery Jr., Nancie Steinberg +1-212-213-0006 arix@burnsmc.com

About Arix Bioscience plc  Arix Bioscience plc is a global healthcare and life science company supporting medical innovation. Headquartered in London and with an office in New York, Arix Bioscience sources, finances and builds world class healthcare and life science businesses addressing medical innovation at all stages of development. Operations are supported by privileged access to breakthrough academic science and strategic relationships with leading research accelerators and global pharmaceutical companies.

Arix Bioscience plc is listed on the Main Market of the London Stock Exchange. For further information, please visit http://www.arixbioscience.com

SOURCE Arix Bioscience plc



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store